ReviewJournal of multidisciplinary healthcare2025
Resistance Exercise as a Safe Modality for Quality of Life Improvement in Patients with Coronary Artery Diseases: A Review.
Review in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Individuals with cardiovascular diseases (CVD) tend to have decreasing cardiorespiratory fitness (CRF), muscle strength, and quality of life (QoL). Because of its multiple benefits, participation in an exercise-based cardiac rehabilitation (CR) program was highly recommended for CVD patients. Currently, there is a trend of increasing the use of resistance exercises (RE) in CR and treatment of CVD, including coronary artery disease (CAD), peripheral arterial disease, and stroke. The application of RE in CVD patients also raises concerns for physicians due to adverse events related to cardiovascular responses. Therefore, this review aimed to explore the effect of RE on cardiovascular responses, cardiovascular risk factors, muscle strength, CRF, and the QoL, including its safety in CAD patients. Articles published in the last ten years were searched using PubMed, Science Direct, Research Gate, and Google Scholar databases using relevant keywords. Studies found that the administration of RE in CAD patients was proven safe when prescribed properly. Some literature showed that RE affected CVD risk factors by improving blood pressure, blood sugar, lipid profile, and body composition. In addition, systemic vascular resistance change led to vasodilatation and reduced blood pressure. Fatal and non-fatal myocardial infarction and mortality also decreased after progressive RE. High-intensity RE was proven to be better at increasing muscle strength compared to low-intensity because it produced a greater increase in the number of myofibrils and neural adaptation. Subsequently, aerobic exercise (AE) combined with RE caused a better increase in CRF. An increase in muscle strength and CRF, as well as diminished symptoms and controlled risk factors obtained from RE administration, increased QoL. To conclude, RE was a safe modality for QoL improvement in CAD patients through controlling risk factors and improving muscle strength and CRF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.